fanft has been researched along with furothiazole in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Combes, RD; Cordeiro, MN; González, MP; Helguera, AM; Pérez, MA | 1 |
Davis, BB; Mattammal, MB; Palmier, MO; Zenser, TV | 1 |
Bryan, GT; Ertürk, E; Headley, DB; Klopp, RG; Michie, PM | 1 |
3 other study(ies) available for fanft and furothiazole
Article | Year |
---|---|
QSAR modeling of the rodent carcinogenicity of nitrocompounds.
Topics: Animals; Drug Evaluation, Preclinical; Female; Neoplasms; Nitro Compounds; Quantitative Structure-Activity Relationship; Rats | 2008 |
Metabolic activation of the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide by prostaglandin H synthase.
Topics: Acetylation; Animals; Biotransformation; Carcinogens; DNA; FANFT; Glutathione; In Vitro Techniques; Kidney Neoplasms; Nitrofurans; Prostaglandin-Endoperoxide Synthases; Protein Binding; Rats; Urinary Bladder Neoplasms | 1984 |
Temporal comparisons of immune status and target organ histology in mice fed carcinogenic 5-nitrofurans and their nornitro analogs.
Topics: Animals; Antibody Formation; Carcinogens; Diet; FANFT; Female; Furans; Immunity, Cellular; Leukemia, Experimental; Lymphoid Tissue; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitrofurans; Thiazoles; Time Factors; Urinary Bladder Neoplasms | 1981 |